| MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies M Panda, E Kalita, S Singh, K Kumar, A Rao, VK Prajapati Life Sciences 305, 120761, 2022 | 42 | 2022 |
| High-throughput virtual screening of small-molecule inhibitors targeting immune cell checkpoints to discover new immunotherapeutics for human diseases S Singh, K Kumar, M Panda, A Srivastava, A Mishra, VK Prajapati Molecular Diversity 27 (2), 729-751, 2023 | 22 | 2023 |
| Translational vaccinomics and structural filtration algorithm to device multiepitope vaccine for catastrophic monkeypox virus S Singh, A Rao, K Kumar, A Mishra, VK Prajapati Computers in Biology and Medicine 153, 106497, 2023 | 14 | 2023 |
| Nanobody-peptide-conjugate (NPC) for passive immunotherapy against SARS-CoV-2 variants of concern (VoC): a prospective pan-coronavirus therapeutics M Panda, E Kalita, S Singh, K Kumar, VK Prajapati Molecular Diversity 27 (6), 2577-2603, 2023 | 9 | 2023 |
| Multi-pathogen based chimeric vaccine to fight against COVID-19 and concomitant coinfections R Ojha, S Singh, N Gupta, K Kumar, AK Padhi, VK Prajapati Biotechnology Letters 45 (7), 779-797, 2023 | 6 | 2023 |
| Apoptotic proteins in Leishmania donovani: in silico screening, modeling, and validation by knock-out and gene expression analysis K Kumar, L Crobu, R Thiam, CC Mandal, Y Sterkers, VK Prajapati Parasite 32, 9, 2025 | | 2025 |
| Quantum‐Enabled Drug Discovery Process A Rao, D Kumari, S Singh, K Kumar, VK Prajapati Drug Delivery Systems Using Quantum Computing, 27-55, 2024 | | 2024 |
| Bioinformatics Approaches in Studying the Fungal Endophyte-Derived Bioactive Compounds with Pharmacological Relevance S Singh, K Kumar, A Rao, VK Prajapati Endophytic Fungi: The Hidden Sustainable Jewels for the Pharmaceutical and …, 2024 | | 2024 |
Vijay K PrajapatiAssociate Professor, Department of Biochemistry, University of Delhi South CampusBestätigte E-Mail-Adresse bei south.du.ac.in